Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma (Phase 1)
Adenocarcinoma, Papillary (Phase 1)
Bronchial Neoplasms (Phase 1)
Carcinoma (Phase 1)
Carcinoma, Bronchogenic (Phase 1)
Carcinoma, Neuroendocrine (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Colonic Diseases (Phase 1)
Colonic Neoplasms (Phase 1)
Colorectal Neoplasms (Phase 1)
Digestive System Diseases (Phase 1)
Digestive System Neoplasms (Phase 1)
Endocrine Gland Neoplasms (Phase 1)
Endocrine System Diseases (Phase 1)
Gastrointestinal Diseases (Phase 1)
Gastrointestinal Neoplasms (Phase 1)
Head and Neck Neoplasms (Phase 1)
Intestinal Diseases (Phase 1)
Intestinal Neoplasms (Phase 1)
Lung Diseases (Phase 1)
Lung Neoplasms (Phase 1)
Neoplasms (Phase 1)
Neoplasms by Histologic Type (Phase 1)
Neoplasms by Site (Phase 1)
Neoplasms, Germ Cell and Embryonal (Phase 1)
Neoplasms, Glandular and Epithelial (Phase 1)
Neoplasms, Nerve Tissue (Phase 1)
Neuroectodermal Tumors (Phase 1)
Neuroendocrine Tumors (Phase 1)
Respiratory Tract Diseases (Phase 1)
Respiratory Tract Neoplasms (Phase 1)
Small Cell Lung Carcinoma (Phase 1)
Thoracic Neoplasms (Phase 1)
Thyroid Cancer, Papillary (Phase 1)
Thyroid Diseases (Phase 1)
Thyroid Neoplasms (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue